Omacetaxine and azacitidine for untreated patients with myelodysplastic syndromes and excess blasts: a phase I/II clinical trial. - Pollyea DA; Stevens BM; Abbott D; Amaya M; Gutman JA; Kent A; McMahon C; Schwartz M; Smith C; Dell-Martin J; Sohalski C; Ellis A; et al. (EClinicalMedicine, 2025)